company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38240000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38240000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14917000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14917000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23323000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4325000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4509000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1958000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10792000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12531000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,54000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,129000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,183000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12714000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4212000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8502000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8502000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8502000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40500000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41191000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40500000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2009.0,Q3,2009-04-01,2009-06-30,2010-08-09 13:52:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.17
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42457000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42457000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16972000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16972000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25485000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4764000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4887000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2078000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11729000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13756000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-118000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-87000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13669000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4748000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8921000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8921000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8921000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40496000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41185000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.22
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40600000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q1,2009-10-01,2009-12-31,2011-02-09 09:01:49+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.17
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31147000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31147000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11006000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11006000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20141000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4323000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4356000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2337000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11016000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9125000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,30000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,110000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,140000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9265000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3285000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5980000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5980000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5980000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40514000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41177000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39900000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q2,2010-01-01,2010-03-31,2011-05-10 10:13:48+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33857000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33857000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12121000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12121000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21736000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4872000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4287000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2128000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,673000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11960000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9776000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,20000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9796000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3372000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6424000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6424000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6424000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40535000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41151000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40200000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q3,2010-04-01,2010-06-30,2010-08-09 13:52:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35539000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35539000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14205000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14205000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21334000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5713000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4720000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1853000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,567000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12853000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8481000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,34000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,155000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,189000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8670000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3348000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5322000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5322000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5322000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40515000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41149000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40400000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2010.0,Q4,2010-07-01,2010-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37263000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37263000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13643000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13643000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23620000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6515000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5687000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2328000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14530000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9090000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,17000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,203000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,220000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9310000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3285000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6025000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6025000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6025000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40615000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41294000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40200000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q1,2010-10-01,2010-12-31,2011-02-09 09:01:49+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41059000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41059000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14803000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14803000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26256000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5635000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6060000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2359000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1240000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15294000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10962000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,27000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,118000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,145000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11107000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3847000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7260000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7260000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7260000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40686000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41348000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40300000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q2,2011-01-01,2011-03-31,2011-05-10 10:13:48+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40052000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40052000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14626000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14626000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25426000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6442000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6143000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2710000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15295000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10131000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,26000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,36000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,62000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10193000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3357000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6836000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6836000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6836000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40737000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41394000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40200000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q3,2011-04-01,2011-06-30,2011-08-09 10:12:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40462000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40462000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17353000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17353000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23109000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6291000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3995000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2425000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,548000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13259000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9850000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,45000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,40000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9890000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3180000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6710000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6710000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6710000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40715000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41358000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40700000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2011.0,Q4,2011-07-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40266000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40266000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15533000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15533000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24733000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6643000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5568000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2273000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,444000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14928000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9805000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,316000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,321000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10126000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3548000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6578000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6578000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6578000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41067000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41487000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41100000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q1,2011-10-01,2011-12-31,2012-02-09 10:46:05+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47441000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47441000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17691000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17691000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29750000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6431000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5781000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2508000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,203000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14923000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14827000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-43000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14792000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5166000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9626000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9626000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9626000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41080000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41620000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41900000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q2,2012-01-01,2012-03-31,2012-05-10 10:16:00+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42141000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42141000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14498000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14498000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27643000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6162000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5843000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2660000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,366000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15031000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12612000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,31000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,45000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12657000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4063000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8594000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8594000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8594000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41091000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41684000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40900000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q3,2012-04-01,2012-06-30,2012-08-09 08:28:08+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42864000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42864000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15942000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15942000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26922000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7136000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4900000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2834000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14870000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12052000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,74000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,89000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12141000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3568000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8573000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8573000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8573000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41080000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41608000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41200000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2012.0,Q4,2012-07-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,45351000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,45351000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16555000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16555000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28796000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7495000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5693000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2517000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15705000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13091000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,128000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,135000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13226000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4752000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8474000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8474000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8474000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41148000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41752000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40400000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q1,2012-10-01,2012-12-31,2013-02-11 09:51:06+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47265000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47265000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16522000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16522000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30743000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7208000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5471000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2811000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15490000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15253000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,257000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,276000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15529000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5280000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10249000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10249000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10249000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41266000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41947000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41000000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q2,2013-01-01,2013-03-31,2013-05-10 09:28:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47108000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47108000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16477000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16477000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30631000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6781000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5440000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2711000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14932000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15699000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-160000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-148000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15551000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5392000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10159000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10159000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10159000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41304000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41983000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40600000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q3,2013-04-01,2013-06-30,2013-08-09 09:32:14+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48962000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48962000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18088000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18088000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30874000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9035000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5820000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2748000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17603000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13271000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-221000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-215000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13056000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3906000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9150000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9150000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9150000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41226000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41895000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41300000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2013.0,Q4,2013-07-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44794000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44794000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16787000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16787000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28007000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7550000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5978000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2853000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16381000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11626000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-220000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-216000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11410000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3984000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7426000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7426000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7426000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41408000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42099000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41300000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q1,2013-10-01,2013-12-31,2014-02-10 09:01:47+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50134000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50134000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18541000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18541000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31593000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6280000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6461000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3186000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15927000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15666000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-28000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15644000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5344000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10300000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10300000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10300000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41471000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42147000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41200000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q2,2014-01-01,2014-03-31,2014-05-12 09:03:48+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47212000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47212000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17970000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17970000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29242000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6715000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6249000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3146000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16110000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13132000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-257000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-252000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12880000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4045000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8835000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8835000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8835000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41478000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42096000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42100000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q3,2014-04-01,2014-06-30,2015-08-10 09:53:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46692000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46692000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18291000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18291000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28401000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6844000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6222000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3367000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16433000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11968000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,196000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,206000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12174000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3992000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8182000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8182000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8182000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41455000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41913000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41400000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2014.0,Q4,2014-07-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48013000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48013000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18776000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18776000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29237000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7385000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6080000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3103000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16568000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12669000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-582000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-576000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12093000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4192000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7901000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7901000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7901000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41607000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41941000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41600000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 08:55:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51545000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51545000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19024000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19024000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32521000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6940000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6481000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3368000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16789000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15732000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-211000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-205000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15527000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5457000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10070000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10070000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10070000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41707000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42048000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42000000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q2,2015-01-01,2015-03-31,2016-05-06 09:03:31+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48204000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48204000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17873000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17873000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30331000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6535000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6184000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3214000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15933000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14398000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-99000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-93000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14305000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5203000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9102000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9102000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9102000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41714000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42093000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.22
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41400000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 09:03:27+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47068000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47068000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17275000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17275000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29793000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6756000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6856000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2920000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16532000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13261000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-128000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-123000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13138000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4671000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8467000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8467000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8467000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41659000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42012000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41800000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2015.0,Q4,2015-07-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47160000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47160000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15577000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15577000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31583000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8173000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6443000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3381000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17997000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13586000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,17000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,96000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,113000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13699000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4806000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8893000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8893000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8893000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41947000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42327000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q1,2015-10-01,2015-12-31,2017-02-09 10:08:53+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51259000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51259000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17687000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17687000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33572000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6875000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7210000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3129000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1202000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18416000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15156000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,43000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-324000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-364000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14792000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5701000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9091000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9091000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9091000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42053000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42425000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41300000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q2,2016-01-01,2016-03-31,2017-05-10 08:51:28+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50665000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50665000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17756000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17756000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32909000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7537000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,8085000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3546000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19168000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13741000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,427000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,65000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-340000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13401000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4647000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8754000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8754000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8754000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42076000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42463000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41700000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q3,2016-03-25,2016-06-30,2017-08-09 09:18:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46998000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46998000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17850000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17850000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29148000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6844000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,8318000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4135000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,956000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20253000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8895000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,427000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,259000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-143000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8752000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3261000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5491000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5491000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5491000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42010000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42393000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41900000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2016.0,Q4,2016-07-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46809000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46809000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17770000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17770000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29039000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7739000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7618000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3597000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18954000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10085000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,423000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-426000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9659000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3380000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6279000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6279000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6279000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42159000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42535000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41900000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q1,2016-10-01,2016-12-31,2018-02-07 11:17:53+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,54125000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,54125000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20648000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20648000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33477000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7274000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,8066000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3951000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19291000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14186000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,408000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,383000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14190000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4878000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9312000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9312000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9312000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42202000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42568000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.22
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q2,2017-01-01,2017-03-31,2018-05-10 08:46:56+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.125
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50140000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50140000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18994000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18994000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31146000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8289000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7961000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3964000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,6628000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26842000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4304000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,407000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,51000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-358000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3946000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3706000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,240000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,240000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,240000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42203000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42593000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24000000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q3,2017-04-01,2017-06-30,2018-08-09 08:11:05+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.125
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,49697000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,49697000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19067000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19067000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30630000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7794000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,8743000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4524000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,134000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,628000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21823000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8807000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,404000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,69000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,162000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-173000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8634000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2908000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5726000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5726000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5726000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42188000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42571000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2017.0,Q4,2017-07-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.12
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52283000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52283000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20273000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20273000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32010000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9202000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,8844000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4420000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,734000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,749000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23949000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8061000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,395000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-80000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-403000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7658000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1356000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6302000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6302000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6302000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42263000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42662000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42000000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q1,2017-10-01,2017-12-31,2019-02-11 16:29:59+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.125
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56451000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56451000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21882000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21882000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34569000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8842000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,8647000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4491000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3458000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1453000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26891000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7678000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,379000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,90000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-165000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-454000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7224000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1936000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5288000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5288000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5288000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42323000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42732000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44100000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q2,2018-01-01,2018-03-31,2019-05-07 15:49:42+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.125
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51737000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51737000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19775000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19775000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31962000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8380000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,8502000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4264000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,913000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1168000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23227000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8735000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,375000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,109000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,151000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-115000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8620000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1795000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6825000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6825000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6825000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42349000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42758000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q3,2018-04-01,2018-06-30,2019-08-07 08:15:18+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.125
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53100000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53100000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20944000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20944000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32156000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8381000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,8475000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3614000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3601000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,975000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25046000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7110000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,371000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,147000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-232000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6878000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1444000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5434000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5434000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5434000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42325000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42754000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42600000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2018.0,Q4,2018-07-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.13
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51480000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51480000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19908000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19908000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31572000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8902000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7563000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3967000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,589000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21021000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10551000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,363000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,149000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,139000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-75000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10476000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2370000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8106000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8106000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8106000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42446000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42905000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q1,2018-10-01,2018-12-31,2020-02-07 11:46:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.125
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50248000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50248000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20910000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20910000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29338000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7388000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6911000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3816000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,785000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,603000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19503000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9835000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,347000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,204000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-445000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-588000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9247000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2153000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7094000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7094000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7094000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42496000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42946000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41700000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q2,2019-01-01,2019-03-31,2020-05-08 08:48:30+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.125
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48440000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48440000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20181000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20181000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28259000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8002000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6747000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4594000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2274000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,178000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21795000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6464000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,448000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,194000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,268000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,14000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6478000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1399000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5079000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5079000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5079000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42639000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42910000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q3,2019-04-01,2019-06-30,2019-08-07 08:15:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50846000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50846000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21690000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21690000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29156000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8710000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7225000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5571000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1588000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,213000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23307000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5849000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,787000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,134000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,160000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-493000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5356000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1253000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4103000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4103000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4103000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42571000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42899000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42800000.0
Meridian Bioscience Inc,VIVO,549300ELSRZEFFFRX195,0000794172,2019.0,Q4,2019-07-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
